Evidence map›Paper›PMID 40196489›Full record

ArticlebioRxiv : the preprint server for biology2025

Defining the host dependencies and the transcriptional landscape of RSV infection and bystander activation.

Sara Sunshine, Andreas Puschnik, Hanna Retallack, Matthew T Laurie, Jamin Liu, Duo Peng, Kristeene Knopp, Matt S Zinter, Chun Jimmie Ye, Joseph L DeRisi

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Sara SunshineDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-1897-5063
Andreas PuschnikChan Zuckerberg Biohub San Francisco, San Francisco, CA, USA.ORCID 0000-0002-9605-9458
Hanna RetallackDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-0533-9102
Matthew T LaurieDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-3526-7368
Jamin LiuDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0001-6386-3709
Duo PengChan Zuckerberg Biohub San Francisco, San Francisco, CA, USA.ORCID 0000-0001-7540-8623
Kristeene KnoppDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-0568-7396
Matt S ZinterDepartment of Pediatrics, Division of Critical Care Medicine, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0003-3351-3278
Chun Jimmie YeInstitute for Human Genetics, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0001-6560-3783
Joseph L DeRisiDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-4611-9205

Funding

Single-cell Mapping Center for Human Regulatory Elements and Gene ActivityUM1HG012076 · NHGRI · STANFORD UNIVERSITY · PI Michael Ryan Corces, Ansuman Satpathy · 2021 to 2026
$13.8M
Project 2: Assessing Brain Dysfunction in Clinically Quiescent SLEP01AI172523 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI MEGGAN MACKAY · 2024 to 2026
$11.4M
Medical Scientist Training Program (T32 NRSA Training Grant)T32GM141323 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Aimee Kao · 2021 to 2026
$10.5M
Sjögren’s Team for Accelerating Medicines Partnership (STAMP)UC2DE032254 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ALAN N BAER, A Darise Farris · 2022 to 2026
$8.8M
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2M
Sjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)U01DE028891 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHIBOSKI, CAROLINE HELENE · 2020 to 2024
$4.0M
Mapping the cell-type-specific molecular and genetic basis of lupus using single cell multiomicsR01AI171184 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Chun Jimmie Ye · 2024 to 2026
$2.4M
Identification and Characterization of the Antiviral Response to RSV Infection: A Single Cell ApproachF31AI150007 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SUNSHINE, SARA · 2020 to 2022
$116k
NHGRI NIH HHS UM1 HG012076NIAID NIH HHS F31 AI150007NIAID NIH HHS P01 AI172523NIAID NIH HHS R01 AI171184NIAMS NIH HHS P30 AR070155NIDCR NIH HHS U01 DE028891NIDCR NIH HHS UC2 DE032254NIGMS NIH HHS T32 GM141323
6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is a globally prevalent pathogen, causes severe disease in older adults, and is the leading cause of bronchiolitis and pneumonia in the United States for children during their first year of life [1]. Despite its prevalence worldwide, RSV-specific treatments remain unavailable for most infected patients. Here, we leveraged a combination of genome-wide CRISPR knockout screening and single-cell RNA sequencing to improve our understanding of the host determinants of RSV infection and the host response in both infected cells, and uninfected bystanders. These data reveal temporal transcriptional patterns that are markedly different between RSV infected and bystander activated cells. Our data show that expression of interferon-stimulated genes is primarily observed in bystander activated cells, while genes implicated in the unfolded protein response and cellular stress are upregulated specifically in RSV infected cells. Furthermore, genome-wide CRISPR screens identified multiple host factors important for viral infection, findings which we contextualize relative to 29 previously published screens across 17 additional viruses. These unique data complement and extend prior studies that investigate the proinflammatory response to RSV infection, and juxtaposed to other viral infections, provide a rich resource for further hypothesis testing.

Indexed as

CRISPR screenhost-pathogen interactionsRSVsingle-cell RNA-seq

Identifiers

PMID40196489
PMCPMC11974880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.